Rattanindia Power Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 5:39 pm

Quick Insight

Rattanindia Power Ltd, currently trading at ₹13.6 per share with a market capitalization of ₹7,293 Cr., exhibits a high P/E ratio of 63.0, indicating potentially overvalued stock. Despite a modest ROE of 4.96% and ROCE of 8.69%, the company's operational efficiency, reflected in a healthy OPM of 23%, suggests room for improvement in profitability. With significant borrowings of ₹3,615 Cr. and negative reserves of ₹-785 Cr., the firm faces financial leverage risks. Moreover, a CCC of 224 days raises concerns about liquidity management. Investors should closely monitor these financial metrics to assess the company's long-term sustainability and growth potential in the power generation/distribution sector.

Competitors of Rattanindia Power Ltd

All Competitor Stocks of Rattanindia Power Ltd

Quarterly Result

Last Updated: August 1, 2025, 1:30 pm

Below is a detailed analysis of the quarterly data for Rattanindia Power Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 822.00 Cr.. The value appears to be declining and may need further review. It has decreased from 936.00 Cr. (Mar 2025) to 822.00 Cr., marking a decrease of 114.00 Cr..
• For Expenses, as of Jun 2025, the value is 725.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 724.00 Cr. (Mar 2025) to 725.00 Cr., marking an increase of 1.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 97.00 Cr.. The value appears to be declining and may need further review. It has decreased from 212.00 Cr. (Mar 2025) to 97.00 Cr., marking a decrease of 115.00 Cr..
• For OPM %, as of Jun 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Mar 2025) to 12.00%, marking a decrease of 11.00%.
• For Other Income, as of Jun 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Mar 2025) to 99.00 Cr., marking an increase of 7.00 Cr..
• For Interest, as of Jun 2025, the value is 148.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 118.00 Cr. (Mar 2025) to 148.00 Cr., marking an increase of 30.00 Cr..
• For Depreciation, as of Jun 2025, the value is 61.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 60.00 Cr. (Mar 2025) to 61.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 126.00 Cr. (Mar 2025) to -13.00 Cr., marking a decrease of 139.00 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 126.00 Cr. (Mar 2025) to -13.00 Cr., marking a decrease of 139.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.02. The value appears to be declining and may need further review. It has decreased from 0.23 (Mar 2025) to -0.02, marking a decrease of 0.25.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:27 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:50 pm

Below is a detailed analysis of the balance sheet data for Rattanindia Power Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 5,370.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5,370.00 Cr..
• For Reserves, as of Mar 2025, the value is -785.00 Cr.. The value appears to be improving (becoming less negative). It has improved from -1,006.00 Cr. (Mar 2024) to -785.00 Cr., marking an improvement of 221.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3,615.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 3,562.00 Cr. (Mar 2024) to 3,615.00 Cr., marking an increase of 53.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,596.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,640.00 Cr. (Mar 2024) to 1,596.00 Cr., marking a decrease of 44.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 9,796.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,566.00 Cr. (Mar 2024) to 9,796.00 Cr., marking an increase of 230.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6,253.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,412.00 Cr. (Mar 2024) to 6,253.00 Cr., marking a decrease of 159.00 Cr..
• For CWIP, as of Mar 2025, the value is 65.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Mar 2024) to 65.00 Cr., marking a decrease of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,478.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,087.00 Cr. (Mar 2024) to 3,478.00 Cr., marking an increase of 391.00 Cr..
• For Total Assets, as of Mar 2025, the value is 9,796.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,566.00 Cr. (Mar 2024) to 9,796.00 Cr., marking an increase of 230.00 Cr..

However, the Borrowings (3,615.00 Cr.) are higher than the Reserves (-785.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Rattanindia Power Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 5. It has decreased from 16.57 (Mar 24) to 0.41, marking a decrease of 16.16.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 5. It has decreased from 16.57 (Mar 24) to 0.41, marking a decrease of 16.16.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 3. It has decreased from 17.28 (Mar 24) to 0.86, marking a decrease of 16.42.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8.54. It has increased from 8.13 (Mar 24) to 8.54, marking an increase of 0.41.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8.54. It has increased from 8.13 (Mar 24) to 8.54, marking an increase of 0.41.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 6.12. It has decreased from 6.26 (Mar 24) to 6.12, marking a decrease of 0.14.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 2. It has decreased from 1.84 (Mar 24) to 1.75, marking a decrease of 0.09.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.30. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.30, marking an increase of 0.17.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.41. This value is within the healthy range. It has decreased from 16.53 (Mar 24) to 0.41, marking a decrease of 16.12.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 2. It has decreased from 16.57 (Mar 24) to 0.41, marking a decrease of 16.16.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 2. It has decreased from 16.57 (Mar 24) to 0.41, marking a decrease of 16.16.
• For PBDIT Margin (%), as of Mar 25, the value is 28.66. This value is within the healthy range. It has decreased from 29.32 (Mar 24) to 28.66, marking a decrease of 0.66.
• For PBIT Margin (%), as of Mar 25, the value is 21.33. This value exceeds the healthy maximum of 20. It has increased from 17.97 (Mar 24) to 21.33, marking an increase of 3.36.
• For PBT Margin (%), as of Mar 25, the value is 6.75. This value is below the healthy minimum of 10. It has decreased from 263.86 (Mar 24) to 6.75, marking a decrease of 257.11.
• For Net Profit Margin (%), as of Mar 25, the value is 6.75. This value is within the healthy range. It has decreased from 264.46 (Mar 24) to 6.75, marking a decrease of 257.71.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.75. This value is below the healthy minimum of 8. It has decreased from 264.46 (Mar 24) to 6.75, marking a decrease of 257.71.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.84. This value is below the healthy minimum of 15. It has decreased from 203.87 (Mar 24) to 4.84, marking a decrease of 199.03.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.05. This value is below the healthy minimum of 10. It has increased from 7.27 (Mar 24) to 8.05, marking an increase of 0.78.
• For Return On Assets (%), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 5. It has decreased from 93.00 (Mar 24) to 2.26, marking a decrease of 90.74.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.71. This value is within the healthy range. It has increased from 0.62 (Mar 24) to 0.71, marking an increase of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.77. This value is within the healthy range. It has increased from 0.72 (Mar 24) to 0.77, marking an increase of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has increased from 0.24 (Mar 24) to 0.33, marking an increase of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 2.95. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.95, marking an increase of 0.67.
• For Quick Ratio (X), as of Mar 25, the value is 2.71. This value exceeds the healthy maximum of 2. It has increased from 2.09 (Mar 24) to 2.71, marking an increase of 0.62.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.68. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 9.68, marking an increase of 9.68.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.97. This value is below the healthy minimum of 3. It has increased from 0.41 (Mar 24) to 1.97, marking an increase of 1.56.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 3. It has increased from 0.26 (Mar 24) to 1.46, marking an increase of 1.20.
• For Enterprise Value (Cr.), as of Mar 25, the value is 8,439.88. It has increased from 7,522.34 (Mar 24) to 8,439.88, marking an increase of 917.54.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.57. This value is within the healthy range. It has increased from 2.24 (Mar 24) to 2.57, marking an increase of 0.33.
• For EV / EBITDA (X), as of Mar 25, the value is 8.96. This value is within the healthy range. It has increased from 7.62 (Mar 24) to 8.96, marking an increase of 1.34.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 1.60, marking an increase of 0.28.
• For Price / BV (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has increased from 1.02 (Mar 24) to 1.15, marking an increase of 0.13.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 1.60, marking an increase of 0.28.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 2.00 (Mar 24) to 0.04, marking a decrease of 1.96.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness